## Clinical Scenario Analysis This patient has **nephrogenic diabetes insipidus (NDI)**: - **Polyuria** (8 L/day) and **polydipsia** (compensatory drinking) - **Hypernatraemia** (Na⁺ 152 mEq/L; normal 135–145) and **hyperosmolality** (310 mOsm/kg; normal 280–295) - **Inappropriately dilute urine** (osmolality 200 mOsm/kg despite hypernatraemia) - **Water deprivation test**: Urine osmolality does NOT increase after desmopressin (DDAVP) — this is the **hallmark of nephrogenic DI** ## Differential: Central vs Nephrogenic DI | Feature | Central DI | Nephrogenic DI | |---------|-----------|----------------| | **Cause** | ADH deficiency | Kidney resistance to ADH | | **After water deprivation** | Increases to > 600 mOsm/kg | Remains < 300 mOsm/kg | | **After desmopressin** | Increases to > 600 mOsm/kg ✓ | **No increase** ✗ | | **Treatment** | Desmopressin (DDAVP) | Sodium restriction + free water; thiazides second-line | **Key Point:** The **desmopressin challenge test** is diagnostic: failure of urine osmolality to rise after DDAVP confirms the kidneys are **unresponsive to ADH** (nephrogenic DI). ## Management of Nephrogenic DI (Harrison's Principles, 21st ed.; Ganong's Review of Medical Physiology) **High-Yield:** NDI management focuses on **reducing urine output** and **preventing hypernatraemia** — NOT replacing ADH (which is already present/elevated but ineffective). ### First-Line Approach: Sodium Restriction + Adequate Free Water Intake 1. **Restrict sodium intake** (low-sodium diet, < 2 g/day) - Reduces the filtered solute load - Decreases obligatory urine output by 30–50% - Creates mild volume contraction → enhanced proximal tubular reabsorption 2. **Increase free water intake** (oral hydration) - Compensates for ongoing polyuria - Prevents worsening hypernatraemia - The patient's polydipsia is a protective mechanism — it should be encouraged, not restricted **Clinical Pearl:** Sodium restriction is the cornerstone of NDI management because it reduces the osmotic load the kidney must excrete, thereby lowering urine volume even when the concentrating mechanism is absent. Free water supplementation simultaneously corrects the existing hypernatraemia. ### Second-Line: Thiazide Diuretics 3. **Thiazide diuretics** (hydrochlorothiazide 25 mg daily) — added if sodium restriction + free water alone are insufficient - Paradoxically reduce urine output in NDI - Mechanism: Mild volume depletion → increased proximal tubular Na⁺ and water reabsorption → less water delivered to the collecting duct - Most effective **in combination with** sodium restriction, not as monotherapy 4. **NSAIDs** (indomethacin) — adjunctive; inhibit prostaglandins, reduce GFR and urine output ## Why Sodium Restriction + Free Water is the Best Next Step In this patient, the immediate priorities are: 1. **Reduce the osmotic load** driving polyuria (sodium restriction) 2. **Correct hypernatraemia** and match ongoing losses (free water) Thiazides are valuable but are second-line and work best when layered on top of dietary sodium restriction. Starting thiazides without sodium restriction is incomplete and less effective. Therefore, Option C (sodium restriction + free water) represents the most appropriate **first** next step. ## Treatment Algorithm ``` Polyuria + Hypernatraemia ↓ Water deprivation test ↓ No urine concentration → Give desmopressin ↓ No response → Nephrogenic DI confirmed ↓ STEP 1: Sodium restriction + Free water intake ← (This patient) ↓ (if insufficient) STEP 2: Add thiazide diuretic ± NSAIDs ``` ## Why Other Options Are Wrong | Option | Why Incorrect | |--------|---------------| | **A — Desmopressin (DDAVP)** | The water deprivation test **explicitly shows no response to desmopressin** — the kidneys are unresponsive to ADH. Giving more DDAVP will not increase urine concentration and is futile in NDI. | | **B — Thiazide diuretic alone** | Thiazides are **second-line** in NDI and are most effective **combined with sodium restriction**. Starting thiazides without first addressing dietary sodium and free water intake is incomplete management. | | **D — Hypertonic saline (3%)** | Hypertonic saline **worsens hypernatraemia** and is absolutely contraindicated here. This patient already has Na⁺ 152 mEq/L. Hypertonic saline is indicated in symptomatic **hypo**natraemia, not hypernatraemia. | **Mnemonic — Causes of Nephrogenic DI (HARDNESS):** - **H**ypercalcaemia / Hyperparathyroidism - **A**myloidosis - **R**enal disease (CKD, post-obstructive) - **D**rugs (lithium, amphotericin B, demeclocycline) - **N**ephrotic syndrome - **E**lectrolyte disorders (hypokalaemia) - **S**ickle cell disease - **S**arcoidosis
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.